Studies involving mice breast tumor models further elaborated that chemotherapy along with HIF inhibitors, such as digoxin (interferes with HIF1α translation) or acriflavine (inhibits dimerization of HIF1α or HIF2α with HIF1β), might improve the survival of BC patients (225–227). The gene discussed is HIF1A; the disease is breast cancer.